首页> 美国卫生研究院文献>Synthetic and Systems Biotechnology >Complete genome sequence of high-yield strain S. lincolnensis B48 and identification of crucial mutations contributing to lincomycin overproduction
【2h】

Complete genome sequence of high-yield strain S. lincolnensis B48 and identification of crucial mutations contributing to lincomycin overproduction

机译:高产菌株林肯链球菌B48的完整基因组序列和鉴定导致林可霉素过量生产的关键突变

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The lincosamide family antibiotic lincomycin is a widely used antibacterial pharmaceutical generated by , and the high-yield strain B48 produces 2.5 g/L lincomycin, approximately 30-fold as the wild-type strain NRRL 2936. Here, the genome of B48 was completely sequenced, revealing a ~10.0 Mb single chromosome with 71.03% G + C content. Based on the genomic information, lincomycin-related primary metabolism network was constructed and the secondary metabolic potential was analyzed. In order to dissect the overproduction mechanism, a comparative genomic analysis with NRRL 2936 was performed. Three large deletions (LDI-III), one large inverted duplication (LID), one long inversion and 80 small variations (including 50 single nucleotide variations, 13 insertions and 17 deletions) were found in B48 genome. Then several crucial mutants contributing to higher production phenotype were validated. Deleting of a MarR-type regulator-encoding gene from LDI, and the whole 24.7 kb LDII in NRRL 2936 enhanced lincomycin titer by 244% and 284%, respectively. Besides, lincomycin production of NRRL 2936 was increased to 7.7-fold when a 71 kb supercluster BGC33 from LDIII was eliminated. As for the duplication region, overexpression of the cluster situated genes and , as well as two novel transcriptional regulator-encoding genes ( and ) elevated lincomycin titer by 77%, 75%, 114% and 702%, respectively. Furthermore, three negative correlation genes ( , and ) on lincomycin biosynthesis, participating in regulation were found out. And surprisingly, inactivation of RNase J-encoding gene and TPR (tetratricopeptide repeat) domain-containing protein-encoding gene achieved lincomycin titer equivalent to 83% and 68% of B48, respectively, to 22.4 and 18.4-fold compared to NRRL 2936. Therefore, the comparative genomics approach combined with confirmatory experiments identified that large fragment deletion, long sequence duplication, along with several mutations of genes, especially regulator genes, are crucial for lincomycin overproduction.
机译:林可酰胺类抗生素林可霉素是由产生的一种广泛使用的抗菌药物,高产菌株B48产生2.5 g / L的林可霉素,约为野生型NRRL 2936的30倍。此处,B48的基因组已完全测序揭示出〜10.0 Mb单染色体,其G + C含量为71.03%。根据基因组信息,构建与林可霉素相关的一级代谢网络,并分析二级代谢潜力。为了剖析生产过剩的机理,使用NRRL 2936进行了比较基因组分析。在B48基因组中发现3个大缺失(LDI-III),1个大反向重复(LID),1个长反向和80个小变异(包括50个单核苷酸变异,13个插入和17个缺失)。然后,验证了几个有助于更高产量表型的关键突变体。从LDI中删除MarR型调节子编码基因以及NRRL 2936中的整个24.7kb LDII分别使林可霉素效价分别提高244%和284%。此外,当淘汰LDIII的71kb超簇BGC33时,林可霉素的NRRL 2936产量增加到7.7倍。至于复制区域,该簇的过表达位于基因和上,以及两个新的转录调节编码基因(和)分别使林可霉素滴度提高了77%,75%,114%和702%。此外,还发现了林可霉素生物合成中参与调节的三个负相关基因(和)。令人惊讶的是,与NRRL 2936相比,灭活RNase J编码基因和TPR(四肽重复序列)域的蛋白质编码基因的林可霉素滴度分别相当于B48的83%和68%,分别为22.4和18.4倍。比较基因组学方法与验证性实验相结合,发现大片段缺失,长序列重复以及基因(尤其是调节基因)的几种突变对于林可霉素的过量生产至关重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号